Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Assets and Liabilities

v3.23.1
Consolidated Statements of Assets and Liabilities - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Investments at fair value    
Non-controlled/non-affiliated investments (amortized cost of $6,719,271 and $5,860,186 at March 31, 2023 and December 31, 2022, respectively) $ 6,653,479 $ 5,716,521
Cash and cash equivalents 120,144 74,241
Interest receivable 62,560 51,778
Deferred financing costs 26,144 20,187
Deferred offering costs 1,231 310
Derivative assets, at fair value 7,489 991
Receivable for investments sold 16,513 8,591
Other assets 271 410
Total assets 6,887,831 5,873,029
LIABILITIES    
Debt (net of unamortized debt issuance costs of $6,922 and $3,572 at March 31, 2023 and December 31, 2022, respectively) 3,001,030 2,342,067
Payable for investments purchased 46,560 0
Interest payable 35,593 17,440
Derivative liabilities, at fair value 4,641 2,136
Due to affiliates 9,845 5,250
Distribution payable 29,860 39,090
Payable for share repurchases 25,769 9,814
Management fees payable (Note 3) 11,188 0
Income based incentive fees payable (Note 3) 14,248 0
Shareholder servicing fee payable 1,106 1,032
Accrued expenses and other liabilities 12,101 928
Total liabilities 3,191,941 2,417,757
Commitments and contingencies
NET ASSETS    
Common Shares, $0.01 par value (151,467,608 and 144,699,650 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively) 1,515 1,447
Additional paid in capital 3,738,603 3,574,281
Distributable earnings (loss) (44,228) (120,456)
Total net assets 3,695,890 3,455,272
Total liabilities and net assets $ 6,887,831 $ 5,873,029